S'abonner

Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases - 05/07/23

Doi : 10.1016/j.jpeds.2023.113408 
Chi-Bo Chen, MD 1, , Jacob Shujui Hsu, PhD 2, , Pei-Lung Chen, MD, PhD 2, 3, 4, Jia-Feng Wu, MD, PhD 1, Huei-Ying Li, PhD 5, Bang-Yu Liou, PhD 1, Mei-Hwei Chang, MD 1, Yen-Hsuan Ni, MD, PhD 1, 5, 6, Wuh-Liang Hwu, MD, PhD 1, 2, 3, Yin-Hsiu Chien, MD, PhD 1, 2, 3, Yen-Yin Chou, MD 7, Yao-Jong Yang, MD, PhD 7, Ni-Chung Lee, MD, PhD 1, 3, , Huey-Ling Chen, MD, PhD 1, 6, 8, ,
1 Department of Pediatrics, National Taiwan University College of Medicine and Children’s Hospital, Taipei, Taiwan 
2 Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei, Taiwan 
3 Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan 
4 Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan 
5 Medical Microbiome Center, National Taiwan University College of Medicine, Taipei, Taiwan 
6 Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan 
7 Department of Pediatrics, National Cheng Kung University Hospital, Taipei, Taiwan 
8 Department of Medical Education & Bioethics, National Taiwan University College of Medicine, Taipei, Taiwan 

Reprint requests: Huey-Ling Chen, MD, PhD, Department of Pediatrics, National Taiwan University College of Medicine and Children’s Hospital, 17F, No. 8, Chung-Shan South Rd, Taipei 100, Taiwan.Department of PediatricsNational Taiwan University College of Medicine and Children’s Hospital17F, No. 8, Chung-Shan South RdTaipei100Taiwan

Abstract

Objectives

To determine how advanced genetic analysis methods may help in clinical diagnosis.

Study design

We report a combined genetic diagnosis approach for patients with clinical suspicion of genetic liver diseases in a tertiary referral center, using tools either tier 1: Sanger sequencing on SLC2SA13, ATP8B1, ABCB11, ABCB4, and JAG1 genes, tier 2: panel-based next generation sequencing (NGS), or tier 3: whole-exome sequencing (WES) analysis.

Results

In a total of 374 patients undergoing genetic analysis, 175 patients received tier 1 Sanger sequencing based on phenotypic suspicion, and pathogenic variants were identified in 38 patients (21.7%). Tier 2 included 216 patients (39 of tier 1-negative patients) who received panel-based NGS, and pathogenic variants were identified in 60 (27.8%). In tier 3, 41 patients received WES analysis, and 20 (48.8%) obtained genetic diagnosis. Pathogenic variants were detected in 6 of 19 (31.6%) who tested negative in tier 2, and a greater detection rate in 14 of 22 (63.6%) patients with deteriorating/multiorgan disease receiving one-step WES (P = .041). The overall disease spectrum is comprised of 35 genetic defects; 90% of genes belong to the functional categories of small molecule metabolism, ciliopathy, bile duct development, and membrane transport. Only 13 (37%) genetic diseases were detected in more than 2 families. A hypothetical approach using a small panel-based NGS can serve as the first tier with diagnostic yield of 27.8% (98/352).

Conclusions

NGS based genetic test using a combined panel-WES approach is efficient for the diagnosis of the highly diverse genetic liver diseases.

Le texte complet de cet article est disponible en PDF.

Keywords : children, infant, jaundice, cholestasis, progressive familial intrahepatic cholestasis

Abbreviations : NGS, NICCD, PCR, PFIC, WES


Plan


 This study was financially supported through grants from the Ministry of Science and Technology, Taiwan (109-2314-B-002-159-MY3), and National Taiwan University Hospital (107-S3917, 108-S4392). The authors have no conflicts of interest to disclose.


© 2023  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 258

Article 113408- juillet 2023 Retour au numéro
Article précédent Article précédent
  • Prevalence of Invasive Bacterial Infection in Hypothermic Young Infants: A Multisite Study
  • Jennifer L. Raffaele, Meenu Sharma, Stephanie Berger, Meredith Mitchell, Clifton Lee, John Morrison, Madhuri Prasad, Monica D. Combs, Kira Molas-Torreblanca, Julie K. Wood, Annalise Van Meurs, Kathryn Westphal, Ali Sawani, Sumeet L. Banker, Jennifer Lee, Coleton King, Elizabeth E. Halvorson, Nicholas M. Potisek, Hypothermic Young Infant Research Collaborative, Saylor McCartor, Vignesh Doraiswamy, Sanford Williams
| Article suivant Article suivant
  • Cost-Effectiveness of Strategies to Identify Children with Perinatally Acquired Hepatitis C Infection
  • Eric W. Hall, Lakshmi Panagiotakopoulos, Carolyn Wester, Noele Nelson, Amy L. Sandul

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.